LINKING SENESCENCE TO MITOCHONDRIAL METABOLIC ALTERATIONS IN MESENCHYMAL STROMAL CELLS FROM MYELODYSPLASTIC SYNDROME PATIENTS

EHA Library, Cesarina Giallongo, 4160019

MULTIPLE EFFECTS OF ARTESUNATE ON THE IMMUNE ENVIRONMENT OF A MYELODYSPLASTIC SYNDROME MODEL

EHA Library, João Vitor Facco, 4160020

DECODING THE STRESS GRANULE PROTEOME REWIRING UPON SPLICING FACTOR MUTATIONS IN MYELOID MALIGNANCIES

EHA Library, Martina Vigorelli, 4160021

ELEVATED EXPRESSION OF HEME METABOLISM HALLMARK GENES AS A FAVORABLE BIOMARKER IN SF3B1-MUTATED MYELODYSPLASTIC NEOPLASMS

EHA Library, Sophia Groh, 4160022

CLONAL DYNAMICS AND CYTOGENETIC COMPLEXITY IN THERAPY-RELATED MYELOID NEOPLASMS: A SINGLE-CENTER STUDY OF 85 CASES

EHA Library, Sara García Ávila, 4160023

HIGH-THROUGHPUT AND HIGHLY SENSITIVE SINGLE CELL GENOTYPING WITH SIMULTANEOUS CHROMATIN ACCESSIBILITY PROFILING IN MYELOID PRECURSOR CONDITIONS

EHA Library, Masanori Motomura, 4160024

THERAPEUTIC TARGETING OF MYELOID CELL CHECKPOINT CLEVER-1 INDUCES ANTI-LEUKEMIA EFFECTS IN MYELOID MALIGNANCIES

EHA Library, Arno Ylitalo, 4160025

C-CBL MUTATIONS AFFECTING RESIDUE 371 CONFER DISMAL PROGNOSIS IN MDS AND CMML

EHA Library, Luca Guarnera, 4160026

MECHANISM OF VISTA UPREGULATING THE FUNCTION OF MDSCS TO MEDIATE THE SUPPRESSION OF CTL CELLS IN MDS PATIENTS

EHA Library, Lijuan Li, 4160027

LIPID METABOLISM CHARACTERISTICS IN THE TRANSITION OF MDS TO SECONDARY AML IN THE BONE MARROW MICROENVIRONMENT

EHA Library, xiaodong lyu, 4160028

DISSECTING METABOLIC ABERRANCIES OF CD34+ PROGENITORS IN MYELODYSPLASTIC SYNDROMES.

EHA Library, Aikaterini Poulaki, 4160029

THE RELATIONSHIP BETWEEN AUTOIMMUNE DISORDERS AND MYELODYSPLASTIC SYNDROME: A BIDIRECTIONAL MENDELIAN RANDOMIZATION STUDY

EHA Library, Linhui Hu, 4160030

MONOCYTES FROM PATIENTS WITH MYELODYSPLASTIC SYNDROME INHIBIT NK CELL-MEDIATED ANTI-TUMOR FUNCTION THROUGH THE CD200/CD200R PATHWAY

EHA Library, Yixuan Guo, 4160031

VARIANT ALLELIC FREQUENCY (VAF) MATTERS: ARTIFICIAL INTELLIGENCE ALGORITHMS HIGHLIGHT VAF INFORMATIONAL VALUE IN ASCERTAINING THE DIAGNOSIS AND THE PROGNOSIS OF MYELOID NEOPLASMS.

EHA Library, Monia Marchetti, 4160032

DECITABINE PLUS ALL-TRANS RETINOIC ACID VERSUS DECITABINE MONOTHERAPY FOR MYELODYSPLASTIC SYNDROMES WITH EXCESS BLASTS: A MULTICENTRE, RANDOMIZED CONTROLLED TRIAL

EHA Library, Xinping Zhou, 4160033

ALLOGENEIC STEM CELL TRANSPLANTATION-RELATED OUTCOMES IN MYELODYSPLASTIC SYNDROMES: ANALYSIS OF A LARGE CONTEMPORARY COHORT

EHA Library, Alexandre Bazinet, 4160034

MYELOID NEOPLASMS FOLLOWING CAR T-CELL THERAPY: THE ROLE OF PRIOR THERAPIES AND CLONAL EVOLUTION

EHA Library, Danielle Hammond, 4160035

A RANDOMIZED, MULTICENTER PHASE II TRIAL OF 3-DAY DECITABINE, 3-DAY AZACITIDINE, OR 5-DAY AZACITIDINE IN LOWER-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Ian Bouligny, 4160036

AN INTEGRATED MACHINE LEARNING-BASED PROGNOSTIC MODEL FOR PATIENTS WITH MYELODYSPLASTIC SYNDROME/NEOPLASMS(MDS)

EHA Library, Xin Wang, 4160037

CONSIDERATION OF UNOBSERVED RISK FACTORS (FRAILTY) ON OVERALL SURVIVAL FOR PATIENTS WITH MYELODYSPLASTIC SYNDROMES WHO UNDERWENT HSCT

EHA Library, Udit Nangia, 4160038

EVALUATING LUSPATERCEPT AS A SUPERIOR TREATMENT FOR ENHANCING CLINICAL AND HRQOL OUTCOMES IN TRANSFUSION-DEPENDENT PATIENTS WITH LOWER-RISK MDS: RESULTS FROM PHASE 3 COMMANDS STUDY

EHA Library, Esther N. Oliva, 4160039

MANAGEMENT OF PATIENTS WITH HEMATOLOGICAL DISORDERS WITH GERMLINE PREDISPOSITIONS IN JAPAN

EHA Library, Mizuki Watanabe, 4160040

PRELIMINARY EFFICACY AND SAFETY ANALYSIS OF THE MAXILUS STUDY OF LUSPATERCEPT (LUSPA) INITIATED AT THE MAXIMUM APPROVED DOSE IN TRANSFUSION-DEPENDENT (TD) LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS)

EHA Library, Matteo Giovanni Della Porta, 4160041

HEMATOLOGIC IMPROVEMENT AND FATIGUE REDUCTION WITH ELRITERCEPT IN PARTICIPANTS WITH LOWER-RISK (LR) MYELODYSPLASTIC NEOPLASMS (MDS) WITH NON-TRANSFUSION DEPENDENT ANEMIA: RESULTS FROM AN ONGOING PHASE 2 TRIAL

EHA Library, David Valcárcel, 4160042

ARTIFICIAL INTELLIGENCE-ENHANCED ANALYSIS OF HMA TREATMENT ON CLINICAL OUTCOMES IN A LARGE COHORT OF MDS PATIENTS: PRELIMINARY RESULTS FROM AN ANALYSIS FROM THE INTERNATIONAL CONSORTIUM FOR MDS (ICMDS) VALIDATE DATABASE

EHA Library, Tariq Kewan, 4160043

APPLICABILITY OF CURRENT PROGNOSTICATION MODELS FOR MDS PATIENTS WITH DDX41 MUTATION

EHA Library, Nadia Toumeh, 4160044

CLINICAL CHARACTERISTICS AND LONG-TERM TREATMENT OUTCOME IN CHILDHOOD MYELODYSPLASTIC NEOPLASM: A NATIONWIDE POPULATION-BASED STUDY IN KOREA

EHA Library, Jung Yoon, 4160045

EFFICACY AND SAFETY OF LUSPATERCEPT AND ERYTHROPOIESIS-STIMULATING AGENT IN PATIENTS WITH MYELODYSPLASTIC NEOPLASMS WITH RING SIDEROBLASTS (MDS-RS): A MULTICENTER REAL-LIFE STUDY.

EHA Library, Thibault Comont, 4160046

CLINICAL AND MOLECULAR CHARACTERIZATION OF ERYTHROID-PREDOMINANT MYELODYSPLASTIC SYNDROMES AND OUTCOMES WITH VENETOCLAX-BASED THERAPY

EHA Library, Alexandre Bazinet, 4160047

PERIPHERAL BLOOD NGS TO INVESTIGATE UNEXPLAINED CYTOPENIAS: EVALUATING A RISK-STRATIFIED APPROACH TO REDUCE BONE MARROW BIOPSIES

EHA Library, Grace Collord, 4160048

ALLO-HSCT IN MDS-H AND MDS-LB PATIENTS: FAVORABLE OUTCOMES DESPITE IPSS-M HIGHER-RISK AND TRANSFUSION DEPENDENCE

EHA Library, Wenjing Guo, 4160049

CPX-351 FOR TRANSPLANT ELIGIBLE, HIGHER RISK PATIENTS WITH MYELODYSPLASTIC SYNDROMES: MOLECULAR RESPONSES AND LONG-TERM FOLLOW-UP

EHA Library, Veronica Guerra, 4160050

IMPROVEMENTS IN HEMATOLOGICAL PARAMETERS AND QUALITY OF LIFE (QOL) WITH ELRITERCEPT: RESULTS FROM AN ONGOING PHASE 2 TRIAL IN PARTICIPANTS WITH LOWER-RISK (LR) MYELODYSPLASTIC NEOPLASMS (MDS)

EHA Library, Aristoteles Giagounidis, 4160051

FLT3 MUTATIONS IN MYELODYSPLASTIC SYNDROMES AND CHRONIC MYELOMONOCYTIC LEUKEMIA: A MULTI-CENTER ANALYSIS

EHA Library, Juan Jose Rodriguez Sevilla, 4160052

INCREASED DURATION OF TIME WITHOUT TRANSFUSION RELIANCE FOR PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES TREATED WITH IMETELSTAT VERSUS PLACEBO IN THE IMERGE TRIAL

EHA Library, Esther N. Oliva, 4160053

ERYTHROID STIMULATING AGENTS IN VEXAS SYNDROME: A MULTICENTER RETROSPECTIVE STUDY OF AN ITALIAN VEXAS COHORT

EHA Library, Elisa Diral, 4160054

INFLUENCE ANALYSIS OF TP53 AND SETBP1 SINGLE NUCLEOTIDE POLYMORPHISMS IN PATIENTS WITH MYELODYSPLASTIC SYNDROME

EHA Library, Wang xianwei, 4160055

ROLE OF PRE-TRANSPLANT MOLECULAR REMISSION ON OUTCOMES OF ALLOGENEIC STEM CELL TRANSPLANT IN MYELODYSPLASTIC SYNDROMES

EHA Library, Sudhamsh Reddy Desai, 4160056

PATIENT-DERIVED EXPANDED POTENTIAL STEM CELLS FROM PNH DEMONSTRATE GLYCOSYL-PHOSPHATIDYL INOSITOL ANCHORED PROTEIN AS A CRITICAL REGULATOR IN HEMATOPOIETIC DEVELOPMENT AND DIFFERENTIATION

EHA Library, Rong Fu, 4160057

IN VIVO EPIGENETIC CRISPR SCREENING IDENTIFIES SMARCA4 AS A CRITICAL TARGET FOR AUTOIMMUNE BONE MARROW FAILURE

EHA Library, Linzhu Tian, 4160058

GENOTYPE-PHENOTYPE ANALYSIS IN GATA2 DEFICIENCY: INSIGHTS FROM 901 INDIVIDUALS

EHA Library, Lili Kotmayer, 4160059

DIHYDROARTEMISININ MODULATES CD4+ T CELL DIFFERENTIATION THROUGH NOTCH SIGNALING IN APLASTIC ANEMIA

EHA Library, Jing Guan, 4160060

THE ROLE OF NK CELLS IN THE IMMUNE ESCAPE PATHOGENESIS OF PATIENTS WITH CLASSICAL PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA

EHA Library, Rong Fu, 4160061

HEROMBOPAG COULD RESTORE HEMATOPOIETIC AND IMMUNE HOMEOSTASIS OF APLASTIC ANEMIA PATIENTS BY REMODELING BONE MARROW MACROPHAGE POLARIZATION VIA ACTIVATING THE PI3K/AKT PATHWAY

EHA Library, Chenyuan Li, 4160062

COMPREHENSIVE MULTIPROTEOMIC ANALYSIS REVEALS AN INFLAMMATORY PHENOTYPE WITH A TH1/17 AXIS IN IMMUNE APLASTIC ANEMIA

EHA Library, Audrey Le Floc'h, 4160063

MULTIPOTENT MESENCHYMAL STROMAL CELLS FROM THE BONE MARROW OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA COMBINED WITH BONE MARROW FAILURE REVEAL PROFOUND CHANGES IN GENE EXPRESSION

EHA Library, Alena Dorofeeva, 4160064

AUTOIMMUNE NEUTROPENIA AND CHRONIC IDIOPATHIC NEUTROPENIA OF CHILDHOOD ARE ASSOCIATED WITH A LOWER PERCENTAGE OF T REGULATORY CELLS

EHA Library, Konstantina Toutoudaki, 4160065

ZALTENIBART, AN ALTERNATIVE PATHWAY OF COMPLEMENT MASP-3 INHIBITOR, IMPROVED HEMATOLOGIC PARAMETERS IN PNH PATIENTS WITH PERSISTENT ANEMIA ON RAVULIZUMAB: ADJUNCTIVE AND MONOTHERAPY TREATMENT PHASES

EHA Library, Morag Griffin, 4160066

THE 2-YEAR SAFETY AND EFFICACY OF IPTACOPAN MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) FROM APPLY- AND APPOINT-PNH STUDIES WHO ENTERED THE ROLL-OVER EXTENSION PROGRAM (REP)

EHA Library, Antonio Risitano, 4160067

EFFICACY AND SAFETY OF POZELIMAB PLUS CEMDISIRAN VERSUS RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA WHO ARE NAÏVE TO COMPLEMENT INHIBITION

EHA Library, Christopher Patriquin, 4160068

CLONAL HEMATOPOIESIS IN SEVERE APLASTIC ANEMIA AND ITS CLINICAL SIGNIFICANCE-ANALYSES OF MUTATIONS IN MYELOID MALIGNANCY-RELATED GENES AND HLA GENES, AS WELL AS LOSS OF HETEROZYGOSITY (LOH) OF HLA

EHA Library, Kuojui Sun, 4160069

2-YEAR EFFICACY AND SAFETY IN PATIENTS (PTS) WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) WHO SELF-ADMINISTERED CROVALIMAB (CROVA) IN THE PHASE III RANDOMIZED COMMODORE 2 TRIAL

EHA Library, Alexander Röth, 4160070

EFFICACY AND SAFETY OF AVATROMBOPAG IN RELAPSED OR REFRACTORY SEVERE APLASTIC ANAEMIA: RESULTS OF THE DIAAMOND-AVA-NEXT TRIAL

EHA Library, Zoe McQuilten, 4160071

DEVELOPMENT OF DATA-DRIVEN MACHINE LEARNING ALGORITHMS TO HELP DIFFERENTIAL DIAGNOSIS BETWEEN INHERITED AND ACQUIRED BONE MARROW FAILURE SYNDROMES

EHA Library, Marta Bortolotti, 4160072

SUSTAINED LONG-TERM CONTROL OF TERMINAL COMPLEMENT ACTIVITY WITH RAVULIZUMAB OR DANICOPAN ADD-ON TO RAVULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Christopher Patriquin, 4160073

ELTROMBOPAG RESTORES T CELL HOMEOSTASIS IN APLASTIC ANEMIA BY MODULATING OXPHOS AND ROS LEVELS

EHA Library, Rong Fu, 4160074

DIAMOND-BLACKFAN ANEMIA SYNDROME BASED ON SPLICE-SITE VARIANTS IN RPS7 IS CHARACTERIZED BY RELATIVELY MILD ANEMIA, CRANIOFACIAL ABNORMALITIES, AND A SUSPECTED HIGH CANCER RISK.

EHA Library, Evangelia Kiakou, 4160075

ADDING HETROMBOPAG TO CYCLOSPORINE FOR FIRST-LINE TREATMENT OF PATIENTS WITH NON-SEVERE APLASTIC ANEMIA: A PHASE 2 MULTI-CENTER CLINICAL STUDY

EHA Library, Lele Zhang, 4160076

REAL-WORLD OUTCOMES AND CLINICAL BURDEN OF PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

EHA Library, Talha Munir, 4160077

EFFECTIVENESS AND SAFETY OF IPTACOPAN IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS WITH PERSISTENT ANEMIA AFTER C5 INHIBITION: THE REAL-WORLD EXPERIENCE OF THE FRENCH EARLY ACCESS PROGRAM

EHA Library, Régis Peffault de Latour, 4160078

EARLY RESPONSE IN COMPLEMENT INHIBITOR NAÏVE PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN IN THE PHASE 3 PRINCE TRIAL

EHA Library, Austin Kulasekararaj, 4160079

APPLICATION OF MACHINE LEARNING IN THE DIAGNOSTIC WORK-UP OF CHRONIC IDIOPATHIC NEUTROPENIA IN ADULTS

EHA Library, Grigorios Tsaknakis, 4160080

CSFR3 MUTATION IN CONGENITAL NEUTROPENIA A LONG STORY: DATA FROM THE ITALIAN REGISTRY

EHA Library, Francesco Pegoraro, 4160081

REAL-WORLD RETROSPECTIVE ANALYSIS OF PEGCETACOPLAN EFFECTIVENESS IN PATIENTS FROM CEE COUNTRIES WITH PNH AND NO OPTIMAL RESPONSE TO C5 INHIBITORS

EHA Library, Łukasz Szukalski, 4160082

INTERIM ANALYSIS OF THE ONGOING COMPLETE STUDY ON THE REAL-WORLD EFFECTIVENESS OF PEGCETACOPLAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Régis Peffault de Latour, 4160083

INHERITED BONE MARROW FAILURE DUE TO GATA2 GENE MUTATION WITH A PREDISPOSITION TO MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIA

EHA Library, Mariia Vasileva, 4160084

VEXINATIONS: A MULTICENTER RETROSPECTIVE STUDY ON VACCINATIONS IN VEXAS SYNDROME

EHA Library, Gregorio Maria Bergonzi, 4160085

DEVELOPMENT OF A PREDICTIVE MODEL FOR ADVERSE MATERNAL AND PERINATAL OUTCOMES IN PREGNANT WOMEN WITH APLASTIC ANAEMIA

EHA Library, Qiuyu Guo, 4160086

PROTEOMIC LANDSCAPE OF CASTLEMAN DISEASE REVEALS THE IRF4-WFS1 AXIS DRIVES PROGRESSION VIA PLASMA CELL DIFFERENTIATION AND SURVIVAL

EHA Library, Peng Liu, 4160087

LRP8-DEPENDENT CHOLESTEROL METABOLISM MODULATES MTORC1 SIGNALING AND APOPTOTIC PATHWAYS IN MULTIPLE MYELOMA

EHA Library, Yue Wang, 4160088

AGE-ASSOCIATED MACROPHAGE POLARIZATION TO AN M2 PHENOTYPE DRIVES MYELOMA PROLIFERATION IN THE AGED BONE MARROW BY LOSS OF TUMOR-ASSOCIATED PHAGOCYTOSIS

EHA Library, Dominic Fowler-Shorten, 4160089

IMMUNE BIOMARKERS OF INCREASED RISK OF INFECTION IN MULTIPLE MYELOMA (MM)

EHA Library, Aintzane Zabaleta, 4160090

DISRUPTION OF NEAT1 DEPENDENT GENE EXPRESSION PROGRAM UNCOVERS NOVEL TARGETABLE VULNERABILITIES IN MULTIPLE MYELOMA.

EHA Library, Noemi Puccio, 4160091

IBERDOMIDE (IBER) TREATMENT ENHANCES MANUFACTURED CAR T CELL EXPANSION AND FUNCTIONALITY AND IS IMMUNOSTIMULATORY IN PATIENTS POST-CAR T CELL THERAPY

EHA Library, Adolfo Aleman, 4160092

CD70/CD27 SIGNALING PROMOTES CLONAL PLASMA CELL EXPANSION IN MULTIPLE MYELOMA AND REPRESENTS A PROMISING THERAPEUTIC TARGET

EHA Library, Maxime Boy, 4160093

SINGLE CELL RNA AND WHOLE GENOME SEQUENCING ANALYSIS REVEAL DISTINCT IMMUNE AND GENOMIC SIGNATURES IN WM PATIENTS RESISTANT TO IBRUTINIB THERAPY

EHA Library, Tina Bagratuni, 4160094

RADIOMICS-BASED RESPONSE PREDICTION IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA

EHA Library, Guneet Janda, 4160095

SELINEXOR POTENTIATES ANTIBODY-DEPENDENT CELLULAR-CYTOTOXICITY (ADCC) AND CAR-NK CELL ACTIVATION AGAINST MULTIPLE MYELOMA CELLS VIA DOWNREGULATION OF HLA-E

EHA Library, Matthew Blunt, 4160096

PRECLINICAL ANALYSIS OF CILTACABTAGENE AUTOLEUCEL COMBINATION STRATEGIES WITH T CELL BISPECIFICS AND DARATUMUMAB TO SUPPORT OPTIMIZATION OF CLINICAL BENEFIT IN MYELOMA PATIENTS

EHA Library, Vicki Plaks, 4160097

DIFFERENTIATING BETWEEN MM-LIKE AND MGUS-LIKE SMOLDERING MYELOMA

EHA Library, Anil Aktas Samur, 4160098

A NOVEL HYPOXIA GENE SIGNATURE FROM THE HOVON-65/GMMG-HD4 PHASE 3 STUDY PROGNOSTIC OF SURVIVAL AND ASSOCIATED WITH IMMUNE SUPPRESSION IN THE TUMOR MICROENVIRONMENT

EHA Library, Catharina Van Elssen, 4160099

IFN-RESPONSIVE STROMAL CELLS DRIVE NON-IMMUNE BONE MARROW NICHE ALTERATIONS IN MULTIPLE MYELOMA PROGRESSION AND VRD TREATMENT RESPONSE

EHA Library, Miguel Cócera, 4160100

ROLE AND MECHANISM OF MULTIPLE MYELOMA CELLS IN REGULATING MACROPHAGE POLARIZATION AND THE ANTITUMOR EFFECT VIA ENO1

EHA Library, Zhaoyun Liu, 4160101

PROGNOSTIC SIGNIFICANCE AND MOLECULAR FUNCTION OF PSMD10 AS A REGULATOR OF PROTEOSTASIS IN MULTIPLE MYELOMA

EHA Library, Zuzanna Tracz-Gaszewska, 4160103

MULTIOMIC IMMUNE BIOMARKERS OF MRD PERSISTENCE IN MULTIPLE MYELOMA

EHA Library, Maria Speciale, 4160104

EXOSOME-DERIVED CIRCCOG5,AS A NEW PROGNOSTIC INDICATOR OF MBD, AGGRAVATED OSTEOLYTIC LESIONS BY CIRCCOG5 / MIR-625-3P / RANKL AXIS

EHA Library, Xing Cui, 4160105

BONE MARROW BREAKOUT LESIONS ACT AS KEY SITES FOR TUMOR-IMMUNE CELL DIVERSIFICATION AND EXHAUSTION IN MULTIPLE MYELOMA

EHA Library, Llorenç Solé-Boldo, 4160106

STUDY ON THE INHIBITION OF LACTATE METABOLISM IN MULTIPLE MYELOMA CELLS TO ENHANCE THE ANTI-TUMOR EFFECT OF BCMA CAR-T CELLS

EHA Library, Zhaoyun Liu, 4160107

EFFICACY AND SAFETY OUTCOMES IN PATIENTS (PTS) WITH RENAL IMPAIRMENT IN THE PHASE 3 DREAMM-7 AND DREAMM-8 TRIALS

EHA Library, Marcelo Pitombeira De Lacerda, 4160108

CARDIAC GLYCOSIDES INDUCE IMMUNOGENIC CELL DEATH IN MYELOMA CELLS AND ENHANCE THE EFFICACY OF THERAPEUTIC ANTIBODIES

EHA Library, Tomoyuki Nakamura, 4160109

MALIGNANT PLASMA CELL-DERIVED CCL2 REPROGRAM MACROPHAGE PROMOTING DISEASE PROGRESSION IN MULTIPLE MYELOMA BONE MARROW MICROENVIRONMENT

EHA Library, HongYan Zhao, 4160110

PROGNOSTIC VALUE AND MUTATIONAL PROFILE OF CIRCULATING CLONAL B CELLS IN WALDENSTRÖM MACROGLOBULINEMIA PATIENTS UNDERGOING IBRUTINIB THERAPY

EHA Library, Tina Bagratuni, 4160111

INHIBITION OF CARBONIC ANHYDRASE IX AS A NEW THERAPEUTIC STRATEGY IN MULTIPLE MYELOMA

EHA Library, Giorgia Gazzaroli, 4160112

COMPREHENSIVE STUDY OF P53 IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS THROUGHOUT THE COMBINATION OF OMICS.

EHA Library, Cristina De Ramón Sánchez, 4160113

HIGH-DIMENSIONAL SPATIAL PROFILING OF THE BONE MARROW MICROENVIRONMENT IN MULTIPLE MYELOMA

EHA Library, Shiva Nickaria, 4160114

INTEGRATING OPTICAL GENOME MAPPING AND NEXT-GENERATION SEQUENCING IN A COHORT OF NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

EHA Library, David Martínez-Campuzano, 4160115

EXPLORATORY BIOMARKERS ASSOCIATED WITH TALQUETAMAB RESISTANCE AND RELAPSE IN THE MONUMENTAL-1 CHINA 400 COHORT BY DATA-DRIVEN UNSUPERVISED CLUSTERING ANALYSIS

EHA Library, Hongmei Xu, 4160116

APPLICATION OF SPATIAL TRANSCRIPTOMICS FOR ANALYZING MULTIPLE MYELOMA

EHA Library, Sandra Haingartner, 4160117

BRAIN MRI FINDINGS IN UNTREATED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)

EHA Library, Wilma Barcellini, 4160118

THE NOVEL RECURRENT FUSION GENE DDX5-EEF1A1 SERVES AS A MOLECULAR BIOMARKER FOR PREDICTING DISEASE PROGRESSION IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) PATIENTS.

EHA Library, Liu Hongchen, 4160119